XML 45 R33.htm IDEA: XBRL DOCUMENT v3.24.2.u1
SHARE-BASED COMPENSATION (Tables)
6 Months Ended
Jun. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Summary of the components and classification of share-based compensation expense
The following table summarizes the components and classification of the Company’s share-based compensation expenses related to stock options and RSUs for the three and six months ended June 30, 2024 and 2023:
Three Months Ended June 30,Six Months Ended
June 30,
(in millions)2024202320242023
Stock options$$$$10 
RSUs 33 29 63 64 
$36 $33 $69 $74 
Research and development expenses$$$$
Selling, general and administrative expenses34 31 64 69 
$36 $33 $69 $74 
Summary of share-based awards
Share-based awards granted for the six months ended June 30, 2024 and 2023 consist of:
Six Months Ended
June 30,
20242023
Bausch Health Share-Based Awards
Stock options
Granted— 999,000 
Weighted-average exercise price$— $9.25 
Weighted-average grant date fair value$— $4.87 
Time-based RSUs
Granted4,626,000 4,667,000 
Weighted-average grant date fair value$9.20 $9.06 
Adjusted Operating Cash Flow performance-based RSUs
Granted1,232,000 647,000 
Weighted-average grant date fair value$9.89 $10.57 
Bausch+ Lomb Share-Based Awards
Stock options
Granted1,317,000 3,130,000 
Weighted-average exercise price$16.85 $18.16 
Weighted-average grant date fair value$4.92 $5.40 
RSUs
Granted3,322,000 2,888,000 
Weighted-average grant date fair value$16.74 $17.97 
TSR performance-based RSUs
Granted826,000 1,175,000 
Weighted-average grant date fair value$21.21 $27.65 
Organic Revenue Growth PSUs
Granted379,000 142,000 
Weighted-average grant date fair value$16.08 $17.96 
OPG PSUs
Granted1,758,000 — 
Weighted-average grant date fair value$17.04 $—